Provide cutting-edge screening technologies and assay development capabilities to fast-track the identification and optimization of potential therapeutic agents.
Designed to deliver suitable animal models to elucidate efficacy and MoA(Mechanism of Action) of drug candidates.
Our In Vitro Biology services are designed to streamline the discovery process through high-throughput screening and assay development.
We specialize in developing and optimizing biochemical and cell-based assays, including ex vivo (blood and tissue based assays) and hydrolysis product identification with LCMS/MS readouts. Our services cover various therapeutic areas, utilizing advanced technologies like nano BRET, alpha LISA, HTRF, and fluorescence polarization. We also offer cancer cell lines and cell line development services through CRISPR.
Our advanced automated systems expedite high-throughput screening across vast chemical libraries, ensuring precision and rapid identification of promising candidates. Each HTS campaign is rigorously validated with optimizations and QC parameters for consistent, accurate results.
Our in vitro analyses reveal drug mechanisms by identifying molecular targets, signaling pathways, and off-target effects, using RTqPCR, western blot, and tailor made assays for comprehensive insights.
In Vivo Biology services encompass a broad spectrum of capabilities designed to translate in vitro discoveries into relavent animal models.
Our end-to-end services include:
We provide a range of animal disease models for oncology, metabolic disorders, inflammation, and pain. Our offerings include xenograft and syngeneic models in oncology. All animals are routinely validated for genotypic traits, with various rodent types available to meet specific study needs.
Our team specializes in designing and conducting preclinical studies to investigate the pharmacokinetics, Pharmacodynamics and overall efficacy of drug candidates. We are also adept at performing comprehensive toxicology evaluations to determine safety profiles.
In Vivo Biology services encompass a broad spectrum of capabilities designed to translate in vitro discoveries into relavent animal models.
Our end-to-end services include:
We provide a range of animal disease models for oncology, metabolic disorders, inflammation, and pain. Our offerings include xenograft and syngeneic models in oncology. All animals are routinely validated for genotypic traits, with various rodent types available to meet specific study needs.
Our team specializes in designing and conducting preclinical studies to investigate the pharmacokinetics, Pharmacodynamics and overall efficacy of drug candidates. We are also adept at performing comprehensive toxicology evaluations to determine safety profiles.
3rd Floor, Ventureast Plaza, Financial District, Nanakramguda, Hyderabad, 500032, Telangana, India
Plot No. 9/A Phase III, IDA Jeedimetla, Hyderabad, Telangana 500055, India
Building 900, Synergy square I, Genome valley, Turkapally, Shameerpet, Hyderabad, Telangana 500078, India
533 Airport Boulevard Suite
400, Burlingame, CA 94010
Interested in working with us?
+91 40 6111 6888
Plot No. 9/A Phase III, IDA Jeedimetla, Hyderabad, Telangana 500055, India
3rd Floor, Ventureast Plaza, Financial District, Nanakramguda, Hyderabad, 500032, Telangana, India
Building 900, Synergy square I, Genome valley, Turkapally, Shameerpet, Hyderabad, Telangana 500078, India
533 Airport Boulevard Suite
400,Burlingame, CA 94010
Interested in working with us?
+91 40 6111 6888